HKD 0.07
(1.56%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 109.55 Million CNY | 13.18% |
2022 | 93.05 Million CNY | -10.4% |
2021 | 103.85 Million CNY | -8.55% |
2020 | 113.56 Million CNY | -3.16% |
2019 | 117.27 Million CNY | 14.54% |
2018 | 102.39 Million CNY | -11.65% |
2017 | 115.88 Million CNY | -10.3% |
2016 | 129.19 Million CNY | 36.64% |
2015 | 94.54 Million CNY | 35.75% |
2014 | 69.65 Million CNY | 7.94% |
2013 | 64.52 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 23.67 Million CNY | -24.4% |
2024 Q2 | 23.67 Million CNY | 0.0% |
2023 Q3 | 23.8 Million CNY | -2.24% |
2023 Q2 | 24.34 Million CNY | -5.8% |
2023 FY | 105.31 Million CNY | 13.18% |
2023 Q1 | 25.84 Million CNY | 3.93% |
2023 Q4 | 31.32 Million CNY | 31.59% |
2022 Q2 | 19.14 Million CNY | -25.35% |
2022 FY | 93.05 Million CNY | -10.4% |
2022 Q3 | 23.4 Million CNY | 22.29% |
2022 Q1 | 25.63 Million CNY | -4.11% |
2022 Q4 | 24.86 Million CNY | 6.24% |
2021 Q1 | 30.68 Million CNY | 8.91% |
2021 FY | 103.85 Million CNY | -8.55% |
2021 Q4 | 26.73 Million CNY | 8.93% |
2021 Q3 | 24.54 Million CNY | 12.18% |
2021 Q2 | 21.88 Million CNY | -28.68% |
2020 Q1 | 26.7 Million CNY | -20.65% |
2020 Q3 | 29.16 Million CNY | -1.26% |
2020 Q2 | 29.53 Million CNY | 10.61% |
2020 FY | 113.56 Million CNY | -3.16% |
2020 Q4 | 28.17 Million CNY | -3.38% |
2019 Q3 | 26 Million CNY | -10.94% |
2019 Q2 | 29.2 Million CNY | 2.76% |
2019 Q1 | 28.41 Million CNY | -15.47% |
2019 FY | 117.27 Million CNY | 14.54% |
2019 Q4 | 33.64 Million CNY | 29.38% |
2018 FY | 102.39 Million CNY | -11.65% |
2018 Q2 | 22.26 Million CNY | -10.45% |
2018 Q3 | 22.96 Million CNY | 3.14% |
2018 Q1 | 24.85 Million CNY | -20.45% |
2018 Q4 | 33.61 Million CNY | 46.41% |
2017 Q3 | 27.41 Million CNY | -4.62% |
2017 Q2 | 28.74 Million CNY | 0.9% |
2017 Q1 | 28.48 Million CNY | -41.3% |
2017 FY | 115.88 Million CNY | -10.3% |
2017 Q4 | 31.25 Million CNY | 14.01% |
2016 FY | 129.19 Million CNY | 36.64% |
2016 Q4 | 48.52 Million CNY | 71.92% |
2016 Q3 | 28.22 Million CNY | 0.13% |
2016 Q1 | 24.26 Million CNY | -18.71% |
2016 Q2 | 28.18 Million CNY | 16.18% |
2015 FY | 94.54 Million CNY | 35.75% |
2015 Q4 | 29.84 Million CNY | 25.28% |
2015 Q2 | 19.55 Million CNY | 0.0% |
2015 Q3 | 23.82 Million CNY | 21.82% |
2014 FY | 69.65 Million CNY | 7.94% |
2013 FY | 64.52 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 46.318% |
Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -667.521% |
China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -185.845% |
Prosperous Future Holdings Limited | 118.15 Million HKD | 7.275% |
Huasheng International Holding Limited | 153.46 Million HKD | 28.611% |
Fourace Industries Group Holdings Limited | 57.65 Million HKD | -90.017% |
Evergreen Products Group Limited | 152.17 Million HKD | 28.005% |
EC Healthcare | 597.44 Million HKD | 81.663% |
Ming Fai International Holdings Limited | 357.68 Million HKD | 69.37% |
Blue Moon Group Holdings Limited | 4.4 Billion HKD | 97.516% |
SuperRobotics Holdings Limited | 15.16 Million HKD | -622.617% |
Takbo Group Holdings Limited | 65.71 Million HKD | -66.706% |
Hyfusin Group Holdings Limited | 196.91 Million HKD | 44.362% |